Market Tracker

12/07 5:09pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

81.02
Delayed Data
As of 3:59pm ET
 -1.97 / -2.37%
Today’s Change
62.12
Today|||52-Week Range
107.56
-22.66%
Year-to-Date
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Dec 04 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close82.99
Today’s open81.36
Day’s range79.50 - 82.34
Volume1,806,512
Average volume (3 months)1,396,072
Market cap$14.3B
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-248.55%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book5.58

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.53-0.63%
VRTXVertex Pharmaceutica...-2.80-3.58%
SGENSeattle Genetics Inc-1.55-2.33%
MYLMylan NV-1.36-3.79%
Data as of 4:02pm ET, 12/07/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts